Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Abstract of this article Free
space
 arrow  Figures/Tables List
space
 arrow  Related articles in Annals
space
 arrow  Articles citing this article
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Marcus, R. H.
space
  arrow  Barlow, J. B.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

ARTICLE

The Spectrum of Severe Rheumatic Mitral Valve Disease in a Developing Country: Correlations among Clinical Presentation, Surgical Pathologic Findings, and Hemodynamic Sequelae

right arrow Richard H. Marcus; Pinhas Sareli; Wendy A. Pocock; and John B. Barlow

1 February 1994 | Volume 120 Issue 3 | Pages 177-183

Objective: To describe the demographic, pathologic, and hemodynamic profiles of patients with severe rheumatic mitral valve disease in a developing country and to assess their relation to uncontrolled rheumatic disease activity.

Design: Retrospective, cross-sectional, cohort study.

Setting: Tertiary medical center in Soweto, South Africa.

Patients: 714 of 737 consecutive black patients, 4 to 73 years old, with pure mitral regurgitation, pure mitral stenosis, or mixed mitral disease who had mitral valve surgery and in whom preoperative and surgical data were concordant.

Measurements: Valve lesions were evaluated on the basis of clinical, echocardiographic, hemodynamic, and surgical pathologic data. Active rheumatic carditis was diagnosed according to clinical evidence for concurrent acute rheumatic fever (Jones criteria), macroscopic appearances at surgery, and histologic findings.

Results: 219 patients had pure mitral regurgitation, 275 had pure mitral stenosis, and 220 had mixed lesions. Ongoing rheumatic activity was diagnosed in 106 patients with pure regurgitation (47%) and in only 5 patients with pure stenosis (2%). Pure regurgitation was the most common lesion in the first and second decades; the relative prevalence of pure stenosis increased with age. Purely regurgitant valves had pliable, unscarred leaflets (95%), dilated mitral annuli (95%), elongated chordae tendineae (92%), and anterior leaflet prolapse (81%). In contrast, purely stenotic valves had fused leaflet commissures (100%) and rigid leaflets (38%) but no evidence of prolapse.

Conclusions: The spectrum of rheumatic mitral valve disease that is hemodynamically severe in developing countries differs from that currently reported in the United States. Severe, pure rheumatic mitral regurgitation is as prevalent as pure stenosis but has an entirely different time course, surgical anatomy, and relation to disease activity, suggesting a separate pathophysiologic mechanism.


Bland and Jones [1], in their benchmark report on rheumatic fever and rheumatic heart disease in 1951, documented a mortality rate of 50% by age 20 years among young patients presenting with rheumatic mitral valve disease before 1920. With the advent of antibiotics, the incidence and severity of rheumatic fever and acute rheumatic carditis have declined markedly in the Western world [2, 3]. In the United States, the decline in rheumatic disease resulting from antimicrobial therapy was so dramatic that several important issues relating to the natural history of this condition have never been resolved. Specifically, the high early mortality rate among young patients with acute rheumatic carditis [1, 4] has not been explained. In this context, Bland and Jones [1] did report a high prevalence of mild mitral regurgitation early in the course of the disease but felt that this lesion was benign. The prevalence and natural history of pure, severe rheumatic mitral regurgitation have not been established, and its unique surgical anatomy has not been well characterized.

In developing areas, where predisposing factors to rheumatic fever persist and prophylactic penicillin therapy is often inadequate, acute rheumatic carditis still frequently follows a fulminant course, resulting in death or severe disability at an early age [5-8]. In South Africa, the sociopolitical situation is such that abject poverty and deprivation are often juxtaposed with sophisticated tertiary care services. The availability of the latter, specifically cardiac surgery, for patients with this disease permitted us to analyze clinical, hemodynamic, and surgical pathologic data that had not been previously correlated.


Methods
space
up arrowTop
dotMethods
down arrowResults
down arrowDiscussion
down arrowAuthor & Article Info
down arrowReferences

We retrospectively studied 748 consecutive patients with rheumatic heart disease who had mitral valve surgery between 1983 and 1986 at Baragwanath Hospital in South Africa. All patients were blacks living either in townships in the environs of the hospital (equivalent to inner-city areas in the metropolitan United States) or in rural areas. Eleven patients in whom concurrent infective endocarditis or primary degenerative leaflet disease (1 patient) confounded evaluation of the hemodynamic severity of the rheumatic lesion itself were excluded from the analysis. Of the remainder, 520 were female and 217, male. Patients ranged in age from 4 to 73 years (mean, 27 ±13 years [±SD]; median, 25 years); 271 (37%) were 20 years of age or younger. All were in New York Heart Association (NYHA) class 3 or 4 and receiving maximal medical treatment.

Preoperative Classification of Valve Lesions

Before surgery, all patients were examined independently by at least two cardiologists. Mitral valve lesions were classified as purely regurgitant, purely stenotic, or mixed according to recognized clinical, radiologic, and echocardiographic criteria [9]. Mitral regurgitation was considered to be pure when associated with unrestricted valve leaflet excursion and a normal mitral orifice area as assessed by two-dimensional echocardiography. Pure mitral stenosis was diagnosed when no clinical or echocardiographic evidence for regurgitation was found. Mixed mitral valve disease was diagnosed when features of both regurgitation and stenosis were present. Cases in which discordance existed among clinical, hemodynamic, and surgical pathologic assessments were excluded from the analysis.

Surgical Evaluation

Hemodynamic Assessment

The hemodynamic severity of valve lesions was confirmed by measurements of left atrial, left ventricular, and right ventricular pressures using fluid-filled catheters connected through strain gauge transducers (Statham, Oxnard, California) to a multichannel recorder (Honeywell Meddars, Lenexa, Kansas). The transmitral end-diastolic gradient (timed according to the R wave on the electrocardiogram) was determined by analysis of simultaneous left atrial and left ventricular pressure recordings. The ratio of left atrial "V" wave to mean left atrial pressure was calculated as an index of the hemodynamic severity of mitral regurgitation [10]. In 74 patients (10%), pressure measurements were not obtained for technical reasons or because of hemodynamic instability.

Surgical Anatomy

After cardiotomy, mitral valves were examined independently by two experienced surgeons according to a standard protocol, implemented in all patients having rheumatic valve surgery at Baragwanath Hospital between 1983 and 1986 at the instigation of one of the surgeons who was then doing research in this area. Valve leaflets were assessed for their pliability as well as for evidence of retraction (scarring) or calcification. Valve commissures were evaluated for evidence of fusion. Mitral valve prolapse was diagnosed at operation if the free edge of one or more scallops of a leaflet, almost invariably the anterior, could be retracted toward the left atrium beyond the free margin of the complementary leaflet and above the plane of the mitral annulus without applying tension to the chordae tendineae [5, 11]. The size of the mitral annulus and the length of the chordae tendineae were assessed. The size of the mitral annulus was graded by inspection using a 4-point scale from 0 (normal size) to 3+ (markedly dilated). In addition, the annular diameter was measured using valve sizers in all patients who had insertion of mechanical prostheses or valve rings (Carpentier, Santa Ana, California). The chordae tendineae were assessed for length (elongated, shortened, or normal), fusion, and evidence of rupture. Among patients who had mitral valvuloplasty, the requirement for chordal shortening procedures was used as ancillary evidence for the presence of chordal elongation.

Surgical Classification of Valve Lesions

The hemodynamic and anatomic features that were considered diagnostic of pure mitral regurgitation included absent or minimal end-diastolic gradient across the mitral valve; pliable, freely mobile mitral valve leaflets; and absence of commissural fusion or subvalvular disease. Pure mitral stenosis was confirmed at surgery in patients with no clinical or echocardiographic evidence for mitral regurgitation when there was marked commissural fusion and a substantial transmitral end-diastolic gradient.

Assessment of Rheumatic Activity

Clinical Evaluation

Rheumatic activity was diagnosed preoperatively when there was serologic evidence for antecedent group A ß-hemolytic streptococcal infection in addition to at least two major (or one major plus two minor) criteria of acute rheumatic fever (revised Jones criteria) [12].

Macroscopic Evaluation

Valves were examined during surgery for the macroscopic features of active rheumatic carditis that have been described [5, 13]: fibrinous pericarditis with epicardial involvement; pinhead vegetations on the free edges of the valve leaflets in the absence of infective endocarditis; and nonspecific signs of acute inflammation including edema, erythema, and hemorrhage within leaflet tissue.

Histologic Evaluation

Where sufficient cardiac tissue was available for adequate histologic assessment, the following light microscopic findings were used as criteria of rheumatic activity [13, 14]: fibrinoid necrosis in valve leaflet or annular tissue; polymorphonuclear or histiocyte infiltration; edema; and neovascularization.

Analysis of Data

For continuous variables, such as pressure data, analysis of variance with the Tukey allowance for multiple comparisons was used to compare three or more groups, and two-sample t-tests were used in instances when only two groups were compared. For categorical data, such as the prevalence of mitral valve prolapse, chi-square tests were used. Three x two contingency tables were constructed to establish the presence of intergroup differences; individual groups were then compared using the Bonferroni correction for multiple comparisons. Statistical differences were recorded using two-tailed P values.


Results
space
up arrowTop
up arrowMethods
dotResults
down arrowDiscussion
down arrowAuthor & Article Info
down arrowReferences

Correlation between Preoperative and Surgical Classification of Valve Lesions

Surgical and preoperative classifications of valve lesions were in agreement in 714 of 737 (97%) cases. The 23 patients in whom discordance existed between the preoperative and surgical assessment of the mitral valve lesion were excluded from the analysis.

Relative Prevalence of Valve Lesions

When the entire patient population was considered, the three types of mitral valve lesion were documented with similar frequency: Two hundred nineteen patients had pure mitral regurgitation (31%), 275 had pure stenosis (38%), and 220 had mixed lesions (31%). However, 36 of 46 patients (78%) who had surgery in the first 10 years of life had pure mitral regurgitation; pure regurgitation was the most common lesion in patients 20 years of age and younger, accounting for 58% of surgically treated rheumatic mitral valve disease (158 of 271 cases) in this age group. Eighty-nine percent (194 of 219) of patients with pure mitral regurgitation were 30 years of age or younger (Figure 1). In contrast, the prevalence of mitral stenosis increased with age. Only 20% of patients with pure stenosis (55 of 275) were less than 20 years of age. Mixed mitral valve disease also increased in frequency until the fourth decade, after which its prevalence declined slightly.



View larger version (15K):
[in this window]
[in a new window]
 
Figure 1. Time-course analysis (by decades) of the relative prevalence of pure mitral regurgitation, mixed mitral valve disease, and pure mitral stenosis. MR = mitral regurgitation; MS = mitral stenosis; MV = mitral valve.

 

Hemodynamic Data

Average values for mean left atrial pressure were similarly increased in all three groups (24 mm Hg for pure regurgitation and pure stenosis and 25 mm Hg for mixed disease). Pure mitral regurgitation was also characterized by a markedly raised left atrial V wave (46 ±18 mm Hg) and an average V wave:mean left atrial pressure ratio of 1.9:1, indicating severe hemodynamic compromise [10]. In addition, left ventricular end-diastolic pressure was elevated, whereas the end-diastolic gradient across the mitral valve was trivial. Pure mitral stenosis was hemodynamically differentiated from pure regurgitation by a high transmitral end-diastolic gradient (15 ±6 mm Hg, P < 0.001 compared with pure regurgitation), an unremarkable left atrial V wave magnitude relative to the mean left atrial pressure, and a normal left ventricular end-diastolic pressure (9 ±15 mm Hg, P < 0.001 compared with pure regurgitation). Mixed lesions had hemodynamic features of both regurgitation and stenosis: The magnitude of the left atrial V wave was intermediate between values for pure regurgitation and stenosis, but the left ventricular end-diastolic pressure was not increased (10 ±5 mm Hg), owing to restricted left ventricular filling across the stenotic mitral orifice. Hemodynamic data are summarized in Table 1.


View this table:
[in this window]
[in a new window]
 
Table 1. Hemodynamic Data

 
Diagnosis of Rheumatic Activity

Immediately before surgery, 107 patients (14%) were considered to have acute rheumatic fever with carditis according to the revised Jones criteria; this was used as presumptive clinical evidence of ongoing rheumatic activity. At surgery, macroscopic features of active carditis were found in 128 of 714 patients (18%). There was agreement between the preoperative clinical and macroscopic surgical diagnosis of rheumatic activity in 98 patients (Table 2). In 9 patients, the macroscopic findings did not confirm the preoperative clinical diagnosis of activity, whereas in 30 patients who did not fulfill the Jones criteria, cardiac tissues appeared to be acutely inflamed at surgery in the absence of clinical evidence for infective endocarditis. Of these 39 patients in whom there was discordance between preoperative clinical and macroscopic surgical diagnosis of ongoing rheumatic activity Table 2, histologic data were available in 18. The histologic findings confirmed the negative preoperative clinical diagnosis in 8 patients, the positive macroscopic surgical diagnosis in 6 patients, and the negative macroscopic surgical diagnosis in 4 patients. Pathologic specimens were obtained in a total of 304 patients, of whom 39 (13%) had histologic evidence for rheumatic activity. Twenty of these patients also tested positive according to clinical and macroscopic criteria, whereas 6 had macroscopic but not clinical features of active carditis. The remaining 13 patients had histologic features of active carditis in the absence of preoperative or surgical criteria for rheumatic activity. Conversely, clinical or macroscopic criteria were positive in 24 patients with no histologic evidence for disease activity.


View this table:
[in this window]
[in a new window]
 
Table 2. Correlation among Clinical (Jones Criteria), Surgical (Macroscopic), and Histologic Diagnosis of Active Rheumatic Carditis

 

Relation of Rheumatic Activity and Valve Lesion

Of 128 patients with surgically diagnosed rheumatic activity, 106 had pure mitral regurgitation (83%); 17, mixed mitral valve disease (13%); and 5, pure stenosis (4%) (Figure 2). Rheumatic activity was diagnosed at surgery in 47% of patients with pure regurgitation, 7% with mixed lesions (P < 0.001 compared with regurgitation), and only 2% with pure stenosis (P < 0.001 compared with regurgitation).



View larger version (43K):
[in this window]
[in a new window]
 
Figure 2. Relations among age, disease activity, and valve lesion. Histograms show the prevalence of rheumatic activity among patients presenting with severe mitral valve disease during the first three decades of life. MR = mitral regurgitation; MS = mitral stenosis; MV = mitral valve.

 

Relation of Rheumatic Activity and Age

Active carditis was not detected in any patient older than 30 years. Macroscopic evidence of ongoing rheumatic activity was found in 28 of 46 having surgery in the first decade of life (60%), 93 of 225 in the second decade (41%), and 7 of 185 in the third decade (4%) (see Figure 2).

Surgical Anatomy of Valve Lesions

Mitral Annulus

The dimensions of the mitral annulus were evaluated at surgery in 314 patients; 257 had dilated annuli (Table 3). Varying degrees of dilatation were recorded in 177 of 186 patients with pure regurgitation (95%) and in 65 of 78 with mixed lesions (83%) but in only 15 of 50 patients with pure stenosis (30%). Mitral prostheses were inserted in 546 patients. The average external diameter of these prostheses was 30 ±2 mm. Despite the young age of patients with pure mitral regurgitation (19 ±11 years), the mean prosthesis external diameter for this group (30 ±2 mm; n = 219) was similar to that for patients with mixed lesions (30 ±2 mm; age, 30 ±12 years; n = 217) and greater (P < 0.001) than that for patients with pure stenosis (29 ±2 mm; age, 31 ±12 years; n = 110).


View this table:
[in this window]
[in a new window]
 
Table 3. Structural Changes in the Mitral Apparatus Seen at Surgery*

 

Chordae Tendineae

Chordal length at surgery was documented in 340 patients. Chordae were elongated in 92% (159 of 173) of patients with pure regurgitation, in 45% (48 of 106) with mixed mitral valve disease, and in only 1 patient with mitral stenosis (Table 3). One hundred eleven patients in whom chordae appeared elongated at surgery had mitral valve repair. All required chordal shortening procedures to prevent anterior leaflet prolapse and to restore valve competency. In contrast, chordae appeared to be shortened in 90% (55 of 61) of patients with pure stenosis, 49% (52 of 106) with mixed mitral valve disease, and only 3% (5 of 173) with pure regurgitation. Chordal rupture was diagnosed at surgery in 57 patients, 44 of whom had pure mitral regurgitation; the remaining 13 patients with chordal rupture had mixed mitral valve disease. Rupture was confined to anterior leaflet chordae in 47 patients. In 1 patient, chordae to anterior and posterior leaflets were involved; another patient had isolated posterior leaflet chordal rupture; and a single patient with severe rheumatic activity had a torn anterolateral papillary muscle. In the remaining 7 patients, the site of rupture was not documented.

Valve Leaflets

Leaflet anatomy was described in 130 patients with pure rheumatic mitral regurgitation (see Table 3). One hundred twenty-three (95%) had pliable mitral leaflets without macroscopic evidence for scarring or commissural fusion. In contrast, leaflets were scarred and rigid (calcified) in 56% of patients with mixed lesions (105 of 187) and in 38% with pure stenosis (104 of 273). All had varying degrees of commissural fusion. The prevalence of leaflet rigidity increased with age. Leaflets were pliable in 72% of patients 30 years of age or younger and rigid in 63% of patients older than 40 years.

Prolapse of the anterior mitral leaflet was confirmed at surgery in 183 of 219 patients (84%) with pure regurgitation. In contrast, prolapse was found in only 22% of patients with mixed lesions and was not documented in any patients with pure stenosis (P < 0.001 compared with pure regurgitation). The prevalence of prolapse among patients with mixed mitral valve disease declined progressively with age, from 60% in the first decade to less than 10% in patients older than 40 years.


Discussion
space
up arrowTop
up arrowMethods
up arrowResults
dotDiscussion
down arrowAuthor & Article Info
down arrowReferences

In developed countries, hemodynamically severe rheumatic mitral valve disease generally presents in the fourth decade or later, with thickened scarred valve leaflets usually manifesting as mitral stenosis with or without concurrent regurgitation [15]. These lesions are the degenerative sequelae of previous rheumatic inflammation and represent the "burned out" end stages of the disease. In our study, the spectrum of hemodynamically severe rheumatic mitral valve disease differed entirely, in that one third of patients presented with pure mitral regurgitation, more often than not in association with uncontrolled ongoing rheumatic activity. Mild mitral regurgitation, manifested by an isolated systolic murmur, is commonly diagnosed in young patients with acute rheumatic fever and carditis but frequently disappears with effective treatment of the acute illness and continued prophylactic penicillin therapy [3, 16, 17]. Our data suggest that in developing countries, this lesion, if left untreated, may progress rapidly to a form of pure mitral regurgitation so severe that early surgery becomes mandatory. Neither the high relative prevalence of pure mitral regurgitation among hemodynamically significant rheumatic mitral valve lesions nor the close association between severe mitral regurgitation and uncontrolled disease activity has, to our knowledge, been described previously. The only published report of a demographically similar subgroup of rheumatic patients found acute carditis with verrucous rheumatic vegetations in 174 of 796 rheumatic patients (22%) studied at autopsy [4]. Sixty-two percent of those patients died before the age of 30 years, but the functional nature of their mitral lesions was not documented, and stenotic and regurgitant lesions were not differentiated. It is conceivable that severe pure regurgitation may have accounted for the unexplained high early mortality rate among the young rheumatic patients reported by Bland and Jones [1] in their benchmark longitudinal study. Many of their patients' deaths were ascribed to an enigmatic "myocardial factor" [1, 18] rarely recognized in rheumatic patients today [7].

Several explanations are possible for the apparent underestimation of the frequency of pure, severe regurgitation among hemodynamically unstable patients with rheumatic mitral valve disease. Jhaveri and colleagues [19] commented that pure mitral regurgitation may have been inappropriately excluded in patients with a mitral mid-diastolic murmur in their own and other studies that relied solely on clinical data. Several large series on pure mitral regurgitation did not include young patients; hence, this important subgroup may have been overlooked [19, 20]. Finally, the high prevalence of hemodynamically significant pure mitral regurgitation reported in this study may be a function of host, environmental, or streptococcal factors that are specific to the geographic area and population studied [21].

The hemodynamically significant regurgitant rheumatic mitral valve lesion has long been considered merely an anatomic variant of its stenotic counterpart, in which retraction of scarred valve leaflets has disrupted the integrity of the mitral seal [15, 20, 22]. Because this chronic degenerative process is usually accompanied by at least some fusion of mitral commissures, the relative prevalence of pure regurgitation among hemodynamically severe mitral valve lesions has consistently been reported to be low [1, 15, 20, 22]. Most of our patients with pure regurgitation had thin, pliable leaflets with none of the scarring, rigidity, calcification, commissural fusion, or chordal shortening to which the regurgitant rheumatic lesion has been traditionally attributed [15, 23]. Most had annular dilatation, chordal elongation, and anterior leaflet prolapse [5]. Annular dilatation has previously been documented in patients with rheumatic mitral regurgitation [7, 13, 22, 24-26], but its role in the pathogenesis of this lesion has not been emphasized. More recently, mitral valve prolapse has been noted in patients with mitral regurgitation after rheumatic fever [27]. Tomaru and coworkers [28] found histologic evidence of previous inflammation (which they assumed to be of rheumatic origin) in valves excised from a group of patients with severe mitral regurgitation caused by mitral valve prolapse. We recently reported 73 patients with pure, severe rheumatic mitral regurgitation, most of whom had marked annular dilatation, chordal elongation, and anterior leaflet prolapse [5]. Concurrent myxomatous involvement of the valve leaflets was observed in only one patient. Thus, the surgical pathologic findings and, presumably, the mechanism of pure severe mitral regurgitation appear to differ from those of the longer-term, slowly progressive stenotic and mixed lesions.

The most striking demographic feature of the hemodynamically significant pure regurgitant lesion reported in our study was its high prevalence among young patients. The mean age of patients with pure mitral regurgitation was 19 ±11 years. The high incidence of concurrent refractory active rheumatic carditis among patients with pure severe mitral regurgitation suggests that uncontrolled rheumatic activity is responsible for clinical expression of this form of rheumatic mitral valve disease that is rarely seen in developed countries. Indeed, histologic examination of valves removed from patients with severe pure rheumatic mitral regurgitation has shown a high incidence of acute plus chronic inflammatory changes, implying that clinically significant regurgitation usually develops after recurrent or persistent rheumatic activity and is virtually never the result of a single episode of carditis [5, 29]. In developing countries, where living conditions are unfavorable, medical facilities are less accessible, and rheumatic fever prophylaxis is suboptimal, the initial acute illness may go unchecked, and more severe disease patterns may be encountered.

Although patients with the more familiar degenerative forms of rheumatic mitral valve disease (mitral stenosis and mixed lesions) were older and demographically similar to those reported in developed countries [20, 22, 30, 31], 20% of our patients with mitral stenosis were 20 years of age or younger. Similar findings have been reported previously from developing countries [6, 33-37]. In contrast, only 1% of patients who have surgical treatment of mitral stenosis in developed countries are under 20 years of age [32]. This may reflect differences in the virulence of the primary rheumatic insult. In more developed communities, older patients with critical stenosis frequently lack a definite history of active rheumatic carditis, reflecting a milder subclinical primary illness with a lesser degree of postinflammatory commissural adhesion [38]. Subsequent progression of the stenotic lesion is thought to be caused by either undetected, recurrent, low-grade rheumatic activity with scarring of the valve [14] or mechanical trauma resulting from altered flow patterns across the deformed mitral orifice [38, 39]. The end point of this process is a deformed, rigid, calcified valve. In contrast, most of our young patients with mitral stenosis had thin, pliable leaflets with no macroscopic evidence of leaflet involvement other than commissural adhesions. These findings could be explained by earlier and more extensive adherence of the leaflet margins after more severe or prolonged acute exudative inflammation, resulting in hemodynamically significant stenosis even before the onset of chronic degenerative sequelae.

In the group of patients with mixed mitral valve disease, demographic and surgical pathologic characteristics of pure regurgitation and pure stenosis overlapped. In most patients, annuli were dilated, but chordae were either elongated with mitral valve prolapse (as in pure regurgitation) or shortened with fibrosed retracted leaflets, as evidenced by the 170 patients in our study with mixed mitral valve disease and no mitral valve prolapse.

Klibanoff and colleagues [40] found frequent dissociation of pathologic from clinical or laboratory evidence for "rheumatic activity". In our study, the presence of acute rheumatic fever according to the Jones criteria was used as presumptive clinical evidence of ongoing "rheumatic activity". The clinical diagnosis of activity correlated well with the macroscopic features of rheumatic activity at surgery, but preoperative predictors failed to detect rheumatic activity in 23% of cases with macroscopic evidence of active disease.

Our data provide new insights into the natural history and pathogenesis of rheumatic mitral valve disease. Differences in the time course, surgical anatomy, and relation to disease activity of pure regurgitant and stenotic lesions suggest different mechanisms for these two end points of a common primary pathologic insult. Despite the cross-sectional nature of this study and the highly selected patient population (hemodynamically severe rheumatic mitral valve disease requiring surgery), these findings may explain the high early morbidity and mortality of rheumatic heart disease in developing countries.


Author and Article Information
space
up arrowTop
up arrowMethods
up arrowResults
up arrowDiscussion
dotAuthor & Article Info
down arrowReferences

From the University of the Witwatersrand, Johannesburg, South Africa.
Requests for Reprints: Richard H. Marcus, MB, FCP(SA), Noninvasive Cardiac Imaging Laboratory, The University of Chicago Medical Center, Department of Medicine/MC5084, 5841 South Maryland Avenue, Chicago, IL 60637.
Acknowledgments: The authors thank Drs. D. Kitchiner and C. Ostermeyer for assistance in the collection of surgical data, Dr. D. Gretler for technical contributions, and Dr. T. Karrison for guidance on statistical analysis of data.
Grant Support: In part by research grant L72 from the Chairman's Fund, Anglo American Corporation of South Africa, and by the Knocker-Bradlow Award of the College of Medicine of South Africa.


References
space
up arrowTop
up arrowMethods
up arrowResults
up arrowDiscussion
up arrowAuthor & Article Info
dotReferences

1. Bland EF, Jones TD. Rheumatic fever and rheumatic heart disease. A twenty year report on 1000 patients followed since childhood. Circulation. 1951; 4:836-43.

2. Kaplan EL, Markowitz M. The fall and rise of rheumatic fever in the United States: a commentary. Int J Cardiol. 1988; 21:3-10.

3. Massell BF, Chute CG, Walker AM, Kurland GS. Penicillin and the marked decreasein morbidity and mortality from rheumatic fever in the United States. N Engl J Med. 1988; 318:280-6.

4. Clawson BJ. Rheumatic heart disease. An analysis of 796 cases. Am Heart J. 1940; 20:454-74.

5. Marcus RH, Sareli P, Pocock WA, Meyer TE, Magalhaes MP, Grieve T, et al. Functional anatomy of severe mitral regurgitation in active rheumatic carditis. Am J Cardiol. 1989; 63:577-84.

6. Padmavati S. Rheumatic fever and rheumatic heart disease in developing countries. Bull World Health Organ. 1978; 56:543-50.

7. Barlow JB, Kinsley RH, Pocock WA: Rheumatic fever and rheumatic heart disease, In: Barlow JB. Perspectives on the Mitral Valve. Philadelphia: F.A. Davis; 1987:227-45.

8. Barlow JB, Marcus RH, Pocock WA, Barlow CW, Essop R, Sareli P. Mechanisms and management of heart failure in active rheumatic carditis. S Afr Med J. 1990; 78:181-6.

9. Braunwald E. Valvular heart disease. In: Braunwald E; ed. Heart Disease. Philadelphia: W.B. Saunders; 1988:1039-42.

10. Grossman W. Profiles in valvular heart disease. In: Grossman W; ed. Cardiac Catheterization and Angiography. Philadelphia: Lea & Febiger; 1986:364-5.

11. Carpentier A, Chavaud S, Fabiani JN, Deloche A, Relland J, Lessana A, et al. Reconstructive surgery of mitral valve incompetence: ten-year appraisal. J Thorac Cardiovasc Surg. 1980; 79:338-48.

12. American Heart Association. Ad hoc committee to revise the Jones criteria (modified) of the council on rheumatic fever and congenital heart disease. Jones criteria (revised) for guidance in the diagnosis of rheumatic fever. Circulation. 1965; 32:664-8.

13. Kinsley RH, Girdwood RW, Milner S. Surgical treatment during the acute phase of rheumatic carditis. In: Nyhus LM, ed. Surgery Annual. v. 13. New York: Appleton-Century-Crofts; 1981:299-323.

14. Edwards WD, Peterson K, Edwards JE. Active valvulitis associated with chronic rheumatic valvular disease and active myocarditis. Circulation. 1978; 57:181-5.

15. Olson LJ, Subramanian R, Ackermann DM, Orszulak TA, Edwards WD. Surgical pathology of the mitral valve: a study of 712 cases spanning 21 years. Mayo Clin Proc. 1987; 62:22-34.

16. Tompkins DG, Boxerbaum B, Liebman J. Long-term prognosis of rheumatic fever patients receiving regular intramuscular benzathine penicillin. Circulation. 1972; 45:543-51.

17. Barlow JB, Pocock WA. The problem of nonejection systolic clicks and associated mitral systolic murmurs: emphasis on the billowing mitral leaflet syndrome. Am Heart J. 1975; 90:636-55.

18. Stollerman GH. Pathology of rheumatic fever. In: Stollerman GH; ed. Rheumatic Fever and Streptococcal Infection. New York: Grune & Stratton; 1975:127-31.

19. Jhaveri S, Czoniczer G, Reider R, Massell BF. Relatively benign "pure" mitral regurgitation of rheumatic origin: a study of seventy-four adult patients. Circulation. 1960; 22:39-48.

20. Waller BF, Morrow AG, Maron BJ, Del Negro AA, Kent KM, McGrath FJ, et al. Etiology of clinically isolated, severe, chronic, pure mitral regurgitation: analysis of 97 patients over 30 years of age having mitral valve replacement. Am Heart J. 1982; 104:276-88.

21. Zabriskie JB. Rheumatic fever: the interplay between host, genetics, and microbe. Circulation. 1985; 71:1077-86.

22. Selzer A, Katayama F. Mitral regurgitation: clinical patterns, pathophysiology and natural history. Medicine (Baltimore). 1972; 51:337-66.

23. Hall RJ, Julian DG. Diseases of the Cardiac Valves. New York: Churchill Livingstone; 1989:143.

24. Du Plessis LA, Chester E. Surgery for severe rheumatic mitral regurgitation in children. J Thorac Cardiovasc Surg. 1969; 58:730-8.[Medline]

25. Bulkley BH, Roberts WC. Dilatation of the mitral annulus. A rare cause of mitral regurgitation. Am J Med. 1975; 59:457-63.

26. Gotsman MS, Van der Horst RL. Surgical management of severe mitral valve disease in childhood. Am Heart J. 1975; 90:685-7.

27. Lembo NJ, Dell'Italia LJ, Crawford MH, Miller JF, Richards KL, O'Rourke RA. Mitral valve prolapse in patients with prior rheumatic fever. Circulation. 1988; 77:830-6.

28. Tomaru T, Uchida Y, Mohri N, Mori W, Furuse A, Asano K. Postinflammatory mitral and aortic valve prolapse: a clinical and pathological study. Circulation. 1987; 76:68-76.

29. Marcus R, Essop R, Meyerowitz C, Levinson G, Middlemost S, Sareli P. Incidence of acute rheumatic mitral valvulitis in young patients with acute rheumatic fever and severe mitral regurgitation (Abstract). Circulation. 1989; 80(Suppl. 2):507.

30. White PD. Heart Disease. 4th ed. New York: Macmillan; 1951: 670-2.

31. Gordis L, Lilienfeld AM, Rodriquez R. A community-wide study of acute rheumatic fever in adults. Epidemiologic and preventive facts. JAMA. 1969; 210:862-5.

32. Bailey CP, Bolton HE. Criteria for and results of surgery for mitral stenosis. N Y Med J. 1956; 56:825-39.

33. Borman JB, Stern S, Shapira T, Milwidsky H, Braun K. Mitral valvotomy in children. Am Heart J. 1961; 61:763-9.

34. Cherian G, Vytilingam KI, Sukumar IP, Gopinath N. Mitral valvotomy in young patients. Br Heart J. 1964; 26:157-66.

35. Gotsman MS, Van der Horst RL, Le Roux BT, Williams MA. Mitral valvotomy in childhood. Thorax. 1973; 28:453-7.

36. John S, Bashi VV, Jairaj PS, Muralidharan S, Ravikumar E, Rajarajeswari T, et al. Closed mitral valvotomy: early results and long-term follow-up of 3724 consecutive patients. Circulation. 1983; 68:891-6.

37. Chesler E, Levin S, Du Plessis L, Freiman I, Rogers M, Joffe N. The pattern of rheumatic heart disease in the urbanized Bantu of Johannesburg. S Afr Med J. 1966; 40:899-904.

38. Selzer A, Cohn KE. Natural history of mitral stenosis: a review. Circulation. 1972; 45:878-90.

39. Wood PH. Diseases of the Heart and Circulation. London: Eyre & Spottiswoode; 1957:517.

40. Klibanoff E, Frieden J, Spagnuolo M, Feinstein AR. "Rheumatic activity". A clinicopathologic correlation. JAMA. 1966; 195:895-900.

Related articles in Annals:

Editorials
Rheumatic Heart Disease in Developing Countries: The Consequence of Inadequate Prevention
Margaret J. McLaren, Milton Markowitz, AND Michael A. Gerber
Annals 1994 120: 243-245. [Full Text]  



This article has been cited by other articles:


Home page
HeartHome page
V. T Nkomo
Epidemiology and prevention of valvular heart diseases and infective endocarditis in Africa
Heart, December 1, 2007; 93(12): 1510 - 1519.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
M. J Antunes and J. B Barlow
Management of tricuspid valve regurgitation
Heart, February 1, 2007; 93(2): 271 - 276.
[Full Text] [PDF]


Home page
ANGIOLOGYHome page
M. Kabukcu, E. Arslantas, I. Ates, F. Demircioglu, and F. Ersel
Clinical, Echocardiographic, and Hemodynamic Characteristics of Rheumatic Mitral Valve Stenosis and Atrial Fibrillation
Angiology, March 1, 2005; 56(2): 159 - 163.
[Abstract] [PDF]


Home page
Eur J EchocardiogrHome page
C. Kaymaz, N. Ozdemir, and M. Ozkan
Differentiating clinical and echocardiographic characteristics of chordal rupture detected in patients with rheumatic mitral valve disease and floppy mitral valve: impact of the infective endocarditis on chordal rupture
Eur J Echocardiogr, March 1, 2005; 6(2): 117 - 126.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
N. D. Hillman, L. Y. Tani, L. G. Veasy, L. L. Lambert, G. B. Di Russo, D. B. Doty, E. C. McGough, and J. A. Hawkins
Current Status of Surgery for Rheumatic Carditis in Children
Ann. Thorac. Surg., October 1, 2004; 78(4): 1403 - 1408.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
L. Y. Tani, L. G. Veasy, L. L. Minich, and R. E. Shaddy
Rheumatic Fever in Children Younger Than 5 Years: Is the Presentation Different?
Pediatrics, November 1, 2003; 112(5): 1065 - 1068.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
C. M. Otto
Evaluation and Management of Chronic Mitral Regurgitation
N. Engl. J. Med., September 6, 2001; 345(10): 740 - 746.
[Full Text] [PDF]


Home page
StrokeHome page
G. W. Petty, B. K. Khandheria, J. P. Whisnant, J. D. Sicks, W. M. O'Fallon, and D. O. Wiebers
Predictors of Cerebrovascular Events and Death Among Patients With Valvular Heart Disease : A Population-Based Study
Stroke, November 1, 2000; 31(11): 2628 - 2635.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. B. Barlow, D. Jankelow, B. A. Carabello, and C. M. Otto
Prospective Study of Asymptomatic Aortic Stenosis • Response • Response
Circulation, April 28, 1998; 97 (16): 1651 - 1653.
[Full Text] [PDF]


Home page
NEJMHome page
J. B. Barlow, R. H. Kinsley, S. R. Fetscher, M. Enriquez-Sarano, and J. Ross
Mitral Regurgitation Due to Flail Leaflet
N. Engl. J. Med., May 1, 1997; 336(18): 1322 - 1324.
[Full Text]


Home page
Ann. Thorac. Surg.Home page
J. B. Barlow, S. J. Middlemost, R. H. Kinsley, B. J. Amsel, I. E. Rodrigus, L. Haenen, and A. C. Moulijn
Biventricular Assist for Severe Acute Rheumatic Pancarditis
Ann. Thorac. Surg., March 1, 1997; 63(3): 920 - 921.
[Full Text]


box Article
 arrow  Table of Contents                
space
 arrow  Abstract of this article Free
space
 arrow  Figures/Tables List
space
 arrow  Related articles in Annals
space
 arrow  Articles citing this article
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Marcus, R. H.
space
  arrow  Barlow, J. B.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space


 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online